Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Publications: group B Streptococcus

2000 to Present:

  • Fairlie, T, Zell, ER, Schrag, SJ.  Effectiveness of Intrapartum Antibiotic Prophylaxis for Prevention of Early-Onset Group B Streptococcal Disease. Obstet Gynecol. 2013;121(3):570-7.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2012 [1 page].
  • Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.  Vaccine. 2013;31(Suppl 4):D52-7.
  • Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013;31(Suppl 4):D20-6.
  • Koumans EH, Rosen J, Van Dyke MK, Zell E, Phares CR, Taylor A, Loft J, and Schrag S for the ABCs and DHAP/RTI team. Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003-2004. Am J of Obstet Gynecology. 2012;206(2):158.e1-158.e11.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2010.
  • Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease — Revised Guidelines from CDC, 2010. MMWR. 2010; Vol 59:RR-10.
  • Centers for Disease Control and Prevention. Trends in Perinatal Group B Streptococcal Disease – United States, 2000-2006. MMWR. 2009;58(5):109-12.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2009.
  • Kothari NJ, Morin CA, Glennen A, Jackson D, Harper J, Schrag SJ, et al. Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007. Emerg Infect Dis. 2009;15(8):1279-81.
  • Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis. 2009;49(1):85-92.
  • Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of Universal Antenatal Screening for Group B Streptococcus. New Engl J Med. 2009; 360(25):2626-36.
  • Castor M, Whitney CG, Como-Sabetti K, Facklam R, Ferrieri P, Bartkus J, et al. Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates. Infect Dis Ob Gyn. 2008:727505,2008.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2008.
  • Dahesh S, Hensler ME, Van Sorge NM, Gertz RE Jr, Schrag S, Nizet V, et al. Point Mutation in the Group B Streptococcal pbp2x Gene Conferring Decreased Susceptibility to Beta-Lactam Antibiotics. Antimicrob Agents Chemother. 2008;52(8):2915-8.
  • Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, et al. Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease: A Multi-State, Population-Based Analysis. Ped Infect Dis J. 2008;27:1057-64.
  • Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005. JAMA. 2008;299(17):2056-65.
  • Phares CR, Schuchat A, Schrag S.J. Invasive group B streptococcal disease in the United States. JAMA. 2008;300(14):1650.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2007.
  • Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005. JAMA. 2007; 299(17):2056-65.
  • Centers for Disease Control and Prevention. Perinatal Group B Streptococcal Disease After Universal Screening Recommendations -- United States, 2003-2005. MMWR. 2007;56(28):701-5.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2006.
  • Schrag SJ, Hadler J, Arnold KE, et al. Risk factors for invasive perinatal Escherichia coli sepsis in the era of widespread intrapartum antibiotic use. Pediatrics. 2006;118(2):570-6.
  • Schrag SJ, Stoll BJ. Early-onset neonatal sepsis in the era of wide-spread intrapartum chemoprophylaxis. Ped Infect Dis J. 2006;25(10):939-40.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2005.
  • Centers for Disease Control and Prevention. Early-Onset and Late-Onset Neonatal Group B Streptococcal Disease – United States, 1996-2004. MMWR. 2005;54(47):1205-8.
  • Eisenberg E, Craig AS, Gautam S et al. Prevention Strategies for Perinatal Group B Streptococcal Disease: Beyond Screening. Ped Infect Dis J. 2005;24:520-4.
  • Law MR, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C, et al. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen. 2005;12:60-8.
  • Morin CA, White K, Schuchat A, Danila RN, Lynfield R. Perinatal group B streptococcal disease prevention, Minnesota. Emerg Infect Dis. 2005;11(9):1467-9.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2004.
  • Centers for Disease Control and Prevention. Diminishing Racial Disparities in Early-Onset Neonatal Group B Streptococcal Disease, United States, 2000-2003. MMWR. 2004;53(No.RR-23):502-5.
  • Centers for Disease Control and Prevention. Laboratory Practices for Prenatal Group B Streptococcal Disease. MMWR. 2004;53(No.RR-23):506-9.
  • Balter S, Zell ER, O’Brien K, Roome A, Noga H, Thayu M, et al. Impact of intrapartum antibiotics on the care and evaluation of the newborn. Pediatr Infect Dis. 2003;22:853-7.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2003.
  • Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis. 2003;3(4):201-13.
  • Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K, et al. Prenatal Screening for Infectious Diseases and Opportunities for Prevention. Obstet Gynecol. 2003;102:753-60.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2002.
  • Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. MMWR. 2002;51(No.RR-11):1-22.
  • Hyde TB, Hilger TM, Reingold A, Farley MM, O’Brien KL, and Schuchat A for the Active Bacterial Core surveillance (ABCs) of the Emerging Infections Program Network. Trends in the incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110(4):690-5.
  • Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig A, et al. A population-based comparison of strategies to prevent early onset group B streptococcal disease in neonates. New Engl J Med. 2002;347:233-9.
  • Schuchat A, Roome A, Zell ER, Linardos H, Zywicki S, O’Brien KL. Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Maternal Child Health J. 2002;6(2):107-14.
  • Baltimore RS, Huie SM, Meek JI, Schuchat A, O’Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics. 2001;108(5):1094-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2001.
  • Farley MM. Group B Streptococcal Infections in Nonpregnant Adults. Clin Infect Dis. 2001;33:556-61.
  • Henning KJ, Hall EL, Dwyer DM, Billmann L, Schuchat A, Johnson JA, et al. Invasive group B streptococcal disease in Maryland nursing home residents. J Infect Dis. 2001;183:1138-42.
  • Schuchat A. Group B streptococcal infections: from trials and tribulations to triumph and trepidation. Clin Infect Dis. 2001;33:751-6.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 2000.
  • Centers for Disease Control and Prevention. Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers- Connecticut and Minnesota. MMWR. 2000;49(11):228-32.
  • Centers for Disease Control and Prevention. Early-onset group B streptococcal disease, United States, 1998-1999. MMWR. 2000;49(35):793-6.
  • Centers for Disease Control and Prevention. Hospital-based policies for prevention of perinatal group B streptococcal disease, United States 1999. MMWR. 2000;49(41):936-40.
  • Factor SH, Whitney CG, Zywicki SS, Schuchat A for the Active Bacterial Core Surveillance Team. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. Obstet Gynecol. 2000;95:377-82.
  • Hager WD, Schuchat A, Gibbs R, Sweet R, Mead P, Larsen JW. Prevention of perinatal group B streptococcal infection: addressing current controversies. Obstet Gynecol. 2000;96:141-5.
  • Schrag S, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: How infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol. 2000:473-83.
  • Schrag SJ, Zywicki S, Farley M, Reingold A, Harrison L, Lefkowitz L, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20.
  • Schuchat A, Schrag S. Group B Streptococcus: from emerging infection to prevention success story. In: Scheld WM, Craig WA, Hughes JM. Emerging Infections 4. Washington, DC: American Society for Microbiology. 2000:107-20.

Top of Page

1995-1999:

  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1999.
  • Centers for Disease Control and Prevention. Laboratory practices for prenatal group B streptococcal screening and reporting. MMWR. 1999;48(20):426-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1998.
  • Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group B streptococcal disease – United States, 1997. MMWR. 1998;47(32):665-70.
  • Harrison LH, Elliot JA, Libonati JP, Billmann L, Schuchat A, Dwyer DM, and the Maryland Bacterial Invasive Disease Surveillance Group. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis. 1998;177:998-1002.
  • Wessels MR, Kasper DL, Johnson KD, Harrison LH. Antibody responses in invasive group B streptococcal infection in adults. J Infect Dis. 1998;178:569-72.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1997.
  • Centers for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease -- United States, 1993-1995. MMWR. 1997;46(21):473-7.
  • Rosenstein NE , Schuchat A, and the Neonatal Group B Streptococcal Disease Study Group. Opportunities for prevention of perinatal group B streptococcal disease: a multi-state surveillance analysis. Obstet Gynecol. 1997;90:901-6.
  • Whitney C, Plikaytis BD, Gozansky W, Schuchat A, Neonatal group B streptococcal disease study group. Prevention practices for perinatal group B streptococcal disease: a multistate surveillance analysis. Obstet Gynecol. 1997;89:28-32.
  • Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliott J, Facklam RR, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis. 1996;173:365-73.
  • Jackson L, Farley M, Schuchat A. Adult group B streptococcal disease. Ann Int Med. 1996;125;152-3.
  • Schuchat A, Whitney C, Zangwill K. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR. 1996;45 (RR-7):1-24.
  • Farley MM. Group B Streptococcal Infection in Older Patients: Spectrum of Disease and Management Strategies. Drugs and Aging. 1995;6:293-300.
  • Harrison LH, Ali A, Dwyer DM, et al. Relapsing invasive group B streptococcal infection in adults. Ann Intern Med. 1995;123:421-7.
  • Jackson L, Hilsdon R, Farley M, Harrison L, Reingold A, Wenger JD, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med. 1995;123:415-20.

Top of Page

1992-1994:

  • Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J. 1994;13:623-9.
  • Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, Wenger JD, et al. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med. 1993;328:1807-11.
  • Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: A population-based economic analysis. JAMA. 1993;270:1442-8.
  • Zangwill KM, Schuchat A, Wenger JD, and the Group B Streptococcal Disease Study Group. Group B streptococcal disease in the United States: Report from a multistate active surveillance system. MMWR. 1992;41[No. SS-6]:25-32.

Top of Page

Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more

External Web Site Policy This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #